《大行報告》瑞信上調廣汽(02238.HK)目標價至11.2元 評級「跑贏大市」
瑞信發表研究報告,指廣汽(02238.HK)首季表現勝預期,純利按年增1897%,主因來自兩日本合營公司的投資收入勝預期。
該行指,雖然因銷量增47%,毛利率按年改善1.3個百分點,但公司本地品牌經營虧損按年增加21%。旗下廣汽埃安則則開始付運AION Y,將有助帶動銷量與利潤。
該行又指,因應投資收入稍勝預期,調升2021至22年盈利預期1.5至2.8%,並計入2023年預測,目標價由11元升至11.2元,維持評級「跑贏大市」,未來主要催化劑為其續航1,000公里之電池發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.